Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry—National Institute of Health. Int J Cardiol 2016;215:193-200.
Comparison of peri-procedural platelet inhibition with prasugrel versus adjunctive cilostazol to dual anti-platelet therapy in patients with ST segment elevation myocardial infarction. J Cardiol 2014;63(2):99-105.
The impact of triple anti-platelet therapy for endothelialization and inflammatory response at overlapping bioabsorbable polymer coated drug-eluting stents in a porcine coronary model. Int J Cardiol 2013;168:1853-1858.
The Impact of Vascular Access for In-Hospital Major Bleeding in Patients with Acute Coronary Syndrome at Moderate- to Very High-Bleeding Risk. J Korean Med Sci 2013;28: 1307-1315.
What is the optimal duration of triple anti-platelet therapy in patients with acute myocardial infarctionundergoing drug-eluting stent implantation? J Cardiol 2011;57(1):53-60.
Efficacy of triple anti-platelet therapy including cilostazol in acute myocardial infarction patients undergoing drug-eluting stent implantation. Korean Circ J 2009;39(5):190-7.
Assessment of Intermediate Coronary Stenosis in Koreans Using the Fractional Flow Reserve. Korean Circ J 2008;38(9):468-474.
